Comparison of O-(2-F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study.

Date publication

mai 2018

Journal

World neurosurgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VERGER Antoine

Tous les auteurs :
Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29510293

Résumé

To compare the diagnostic performance of O-(2-F-fluoroethyl)-L-tyrosine (F-FET) positron emission tomography (PET) and perfusion-weighted magnetic resonance imaging (PWI) for the diagnosis of progressive or recurrent glioma.

Mots clés

Adult, Aged, Brain Neoplasms, diagnostic imaging, Cohort Studies, Disease Progression, Female, Glioma, diagnostic imaging, Humans, Magnetic Resonance Imaging, methods, Male, Middle Aged, Neoplasm Recurrence, Local, diagnostic imaging, Pilot Projects, Positron-Emission Tomography, methods, Tyrosine, analogs & derivatives

Référence

World Neurosurg. 2018 May;113:e727-e737